Citigroup Inc Ocular Therapeutix, Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Citigroup Inc holds 136,022 shares of OCUL stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,022

Previous 64,310 111.51%

Holding current value

$1.35 Million

Previous $439,000 169.48%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.45 - $9.23 $462,542 - $661,901	71,712 Added 111.51%	136,022 $1.18 Million
Q2 2024 Aug 12, 2024	SELL	$4.2 - $8.69 $226,779 - $469,216	-53,995 Reduced 45.64%	64,310 $439,000
Q1 2024 May 10, 2024	BUY	$3.85 - $10.93 $381,642 - $1.08 Million	99,128 Added 516.91%	118,305 $1.08 Million
Q4 2023 Feb 09, 2024	SELL	$2.08 - $4.52 $1,986 - $4,316	-955 Reduced 4.74%	19,177 $85,000
Q3 2023 Nov 09, 2023	SELL	$3.14 - $5.04 $50,280 - $80,705	-16,013 Reduced 44.3%	20,132 $63,000
Q2 2023 Aug 10, 2023	BUY	$4.6 - $7.64 $81,516 - $135,388	17,721 Added 96.18%	36,145 $186,000
Q1 2023 May 11, 2023	BUY	$2.79 - $6.27 $30,614 - $68,800	10,973 Added 147.27%	18,424 $97,000
Q4 2022 Feb 09, 2023	SELL	$2.61 - $4.41 $1,521 - $2,571	-583 Reduced 7.26%	7,451 $20,000
Q3 2022 Nov 10, 2022	SELL	$4.09 - $6.5 $807,844 - $1.28 Million	-197,517 Reduced 96.09%	8,034 $33,000
Q2 2022 Aug 10, 2022	BUY	$3.01 - $5.22 $557,494 - $966,817	185,214 Added 910.72%	205,551 $826,000
Q1 2022 May 12, 2022	SELL	$4.83 - $7.35 $61,625 - $93,778	-12,759 Reduced 38.55%	20,337 $101,000
Q4 2021 Feb 10, 2022	SELL	$6.16 - $12.07 $77,375 - $151,611	-12,561 Reduced 27.51%	33,096 $231,000
Q3 2021 Nov 10, 2021	BUY	$9.7 - $14.34 $442,872 - $654,721	45,657 New	45,657 $457,000

Others Institutions Holding OCUL

# of Institutions

172

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $764M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account